We are pleased to announce the publication of the academic review titled “Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications” in the international academic journal Biomedicines on June 17, 2024.
This review is a result of collaborative efforts by experts from various institutions including the Osaka University Graduate School of Medicine. It was authored by a distinguished research group that includes Professor Hideshi Ishii from Osaka University, our company’s CEO Takaaki Hirotsu, and CTO Eric di Luccio.
The review provides an in-depth analysis of the role of tissue-resident memory T cells (Trm cells) in gastrointestinal cancers, exploring their prognostic significance and potential therapeutic applications.
Key Highlights of the Review
Prognostic Significance: The presence of Trm cells in the tumor microenvironment of gastrointestinal cancers is shown to be closely associated with improved patient outcomes and increased survival rates. The review emphasizes the importance of Trm cells as prognostic markers in these cancers.
Therapeutic Applications: Trm cells are strongly suggested to enhance the efficacy of immune checkpoint inhibitors (ICI). The review discusses the potential for targeting these Trm cells to revolutionize cancer treatment strategies.
Comprehensive Analysis: Authored by a team of experts, the review delves into the unique characteristics and functions of Trm cells, examining their impact on tumor progression, prognosis improvement, immune surveillance, and effective antitumor response. It also explores therapeutic strategies for advancements in cancer immunotherapy.
For further details, please visit the official MDPI website.
■Publication Details:
Title: Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications
・Title: Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications
・Journal: Biomedicines
・Publication Date: June 17, 2024
・DOI: 10.3390/biomedicines12061342
・Access: This review is available under open access and distributed under the terms of the Creative Commons Attribution (CC BY) license.
■About the Journal “Biomedicines”:
Biomedicines is a prestigious peer-reviewed journal that publishes innovative research in the field of biomedical sciences. Its aim is to disseminate significant scientific discoveries and foster the exchange of knowledge between researchers and clinicians.
The international biomedical journal Biomedicines has just published a peer-reviewed review article* on data showing the effectiveness of N-NOSE . . .
2024.11.15At the Excellence in Oncology Care (EIOC) 2024 conference held in Dubai from October 11 (Fri.) to 13 (Sun.), 2024, our Shonan R&D Center Res . . .
2024.10.25We, HIROTSU BIO SCIENCE Inc., participated in the Excellence in Oncology Care (EIOC) 2024 conference that was held in Dubai from October 11th (F . . .
2024.10.17